dihydroergocristine (BioDeep_00000398552)

   


代谢物信息卡片


dihydroergocristine

化学式: C35H41N5O5 (611.3108)
中文名称: 双氢麦角汀
谱图信息: 最多检出来源 not specific(not specific) 0%

分子结构信息

SMILES: CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
InChI: InChI=1S/C35H41N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41)

描述信息

Ergocristine in which a single bond replaces the double bond between positions 9 and 10. It is used as the mesylate salt for the symptomatic treatment of mental deterioration associated with cerebrovascular insufficiency and in peripheral vascular disease.
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AE - Ergot alkaloids
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Origin: Microbe; SubCategory_DNP: Alkaloids derived from tryptophan, Ergot alkaloids, Clavine alkaloid
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.971
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.968
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.966
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.965

同义名列表

1 个代谢物同义名

dihydroergocristine



数据库引用编号

24 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Nahida Tabassum, Feroz Ahmad. Role of natural herbs in the treatment of hypertension. Pharmacognosy reviews. 2011 Jan; 5(9):30-40. doi: 10.4103/0973-7847.79097. [PMID: 22096316]
  • Beatriz Bicalho, Juliana Marconi Giolo, Sergio Lilla, Gilberto De Nucci. Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary results. Biopharmaceutics & drug disposition. 2008 Jan; 29(1):17-28. doi: 10.1002/bdd.585. [PMID: 17941060]
  • P Jerie. [Milestones of cardiovascular therapy. IV. Reserpine]. Casopis lekaru ceskych. 2007; 146(7):573-7. doi: . [PMID: 17722843]
  • Beatriz Bicalho, Giovanni C Guzzo, Sergio Lilla, Hilton O Dos Santos, Gustavo D Mendes, Giuseppe Caliendo, Elisa Perissutti, Anna Aiello, Paolo Luciano, Vicenzo Santagada, Alberto S Pereira, Gilberto De Nucci. Pharmacokinetics of dihydroergocristine and its major metabolite 8'-hydroxy-dihydroergocristine in human plasma. Current drug metabolism. 2005 Dec; 6(6):519-29. doi: 10.2174/138920005774832669. [PMID: 16379666]
  • Kazuto Yasuda, Lu-Bin Lan, Dominique Sanglard, Katryn Furuya, John D Schuetz, Erin G Schuetz. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. The Journal of pharmacology and experimental therapeutics. 2002 Oct; 303(1):323-32. doi: 10.1124/jpet.102.037549. [PMID: 12235267]
  • Sean Ekins, Richard B Kim, Brenda F Leake, Anne H Dantzig, Erin G Schuetz, Lu-Bin Lan, Kazuto Yasuda, Robert L Shepard, Mark A Winter, John D Schuetz, James H Wikel, Steven A Wrighton. Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein. Molecular pharmacology. 2002 May; 61(5):964-73. doi: 10.1124/mol.61.5.964. [PMID: 11961113]
  • I Setnikar, K Schmid, L C Rovati, B Vens-Cappell, D Mazur, I Kozak. Bioavailability and pharmacokinetic profile of dihydroergotoxine from a tablet and from an oral solution formulation. Arzneimittel-Forschung. 2001 Jan; 51(1):2-6. doi: 10.1055/s-0031-1299995. [PMID: 11215321]
  • J M Grognet, R Rivière, M Istin, A Zanotti, G Coppi. [The pharmacokinetics of dihydroergocristine after intravenous and oral administration in rats]. Arzneimittel-Forschung. 1992 Nov; 42(11A):1394-6. doi: NULL. [PMID: 1492859]
  • P Chopin, M Briley. Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology. 1992; 106(1):26-30. doi: 10.1007/bf02253584. [PMID: 1738791]
  • F Nimmerfall, J Rosenthaler. Ergot alkaloids: hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine. Journal of pharmacokinetics and biopharmaceutics. 1976 Feb; 4(1):57-66. doi: 10.1007/bf01271444. [PMID: 1271240]